Mike Palmer

Mike Palmer is the Head of Vaccines and Immune Therapies, Global Market Access and Pricing at AstraZeneca. With a strong background in healthcare and pharmaceuticals, they previously served as a Trustee for Bridge Renewal Trust and held various roles at PwC and Sg2. Mike has developed innovative value strategies in multiple therapeutic areas, including respiratory and immunology, as well as cardiovascular, renal, and metabolic diseases. They earned a First Class MA in Natural Sciences and Management Studies from the University of Cambridge and an MSc with Distinction in International Primary Health Care from University College London.